Synnovation Therapeutics, Inc.
đşđ¸United States
- Country
- đşđ¸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.synnovationtx.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)⢠Click on a phase to view related trials
Phase 1
2 (100.0%)SNV4818 in Participants With Advanced Solid Tumors
- First Posted Date
- 2024-12-17
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- Pikavation Therapeutics, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT06736704
- Locations
- đşđ¸
Massachusetts General Hospital, Boston, Massachusetts, United States
đşđ¸Thomas Jefferson University-Sidney Kimmel Cancer Center, Philadelphia, Pennsylvania, United States
đşđ¸Sarah Cannon Research Institute, Nashville, Tennessee, United States
SNV1521 in Participants with Advanced Solid Tumors
Phase 1
Recruiting
- Conditions
- Advanced Solid Tumor
- Interventions
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2025-03-13
- Lead Sponsor
- Synnovation Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06220864
- Locations
- đşđ¸
Yale University, New Haven, Connecticut, United States
đşđ¸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
đŚđşPrincess Alexandra Hospital, Woolloongabba, Queensland, Australia
News
No news found